What is Kawasaki Disease Medicines Access Program?
Kawasaki disease is a rare condition which is common in children less than 5 years old and of Asian descent. Approximately 20% of cases will lead to coronary aneurysms if left untreated, which can cause myocardial infarction in the young. Inflammation of the coronary arteries, heart muscle, lining, valves, and the outer membrane around the heart may occur which can lead to death. However, if symptoms are detected in the first ten (10) days of illness, patients have a high chance of recovery with a decreased risk for a coronary aneurysm.
Human Immunoglobulin (IVIG), the medicine that is widely used to reduce the risk of damage to the coronary arteries of the heart, costs more than the salary of an ordinary Filipino minimum wage earner. Non-compliance due to poor access to medicine contributes to the increasing number of Kawasaki Disease cases in the country. This is classified as an essential drug included in the current edition of the Philippine National Formulary (PNF) but there has been a wide gap in making the medicine accessible to patients because of its prohibitive cost.
To improve access to this life-saving medicine that will help reduce the mortality rate among children and will improve their health outcomes, the Pharmaceutical Division (PD) under the Office for Health Regulation has collaborated with the Philippine Heart Center (PHC) to develop the Kawasaki Disease Medicines Access Program (KDMAP), which shall provide human immunoglobulin (IVIG) to all patients suffering from the said condition in selected government hospitals nationwide.
To improve health outcomes of Filipino patients suffering from Kawasaki Disease
- To provide access to Human Immunoglobulin for Kawasaki disease patients especially the poor Filipino children
- To prevent further complications like coronary abnormalities (heart damage)
- To reduce mortality rate especially among children.
List of Access Sites
|1. Philippine Heart Center||19. Jose B. Lingad Memorial Regional Hospital|
|2. Philippine Children's Medical Center||20. Batangas Medical Center|
|3. National Children's Hospital||21. Bicol Regional Training and Teaching Hospital|
|4. Rizal Medical Center||22. Bicol Sanitarium|
|5. Jose R. Reyes Memorial Medical Center||23. Bicol Medical Center|
|6. East Avenue Medical Center||24. Corazon Locsin Montelibano Memorial Regional Hospital|
|7. Research Institute for Tropical Medicine||25. Western Visayas Medical Center|
|8. Las Piñas General Hospital and Satellite Trauma Center||26. Don Emilio Del Valle Memorial Hospital|
|9. Quirino Memorial Medical Center||27. Vicente Sotto Memorial Medical Center|
|10. Ilocos Training and Regional Medical Center||28. Gov. Celestino Gallares Memorial Hospital|
|11. Region I Medical Center||29. Eversley Childs Sanitarium|
|12. Mariano Marcos Memorial Hospital and Medical Center||30. Eastern Visayas Regional Medical Center|
|13. Baguio General Hospital and Medical Center||31. Zamboanga City Medical Center|
|14. Cagayan Valley Medical Center||32. Sulu Sanitarium|
|15. Veterans Regional Hospital||33. Mayor Hilarion A. Ramiro Sr. Regional Training and Teaching Hospital|
|16. Bataan General Hospital||34. Northern Mindanao Medical Center|
|17. Dr. Paulino J. Garcia Memorial Research and Medical Center||35. Southern Philippines Medical Center|
|18. Talavera Extension Hospital|
The following are the medicines included in the program:
1. Human Immunoglobulin 50 mg/mL, 50 mL vial
2. Human Immunoglobulin 50 mg/mL, 100 mL vial